Timothy A. Springer - 02 Oct 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Issuer symbol
RNAC
Transactions as of
02 Oct 2024
Net transactions value
+$4,293,545
Form type
4
Filing time
04 Oct 2024, 17:58:13 UTC
Previous filing
27 Sep 2024
Next filing
24 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Other +1,801,314 +30% 7,818,045 02 Oct 2024 Direct F1
transaction RNAC Common Stock Purchase $95,822 +5,514 +0.07% $17.38 7,823,559 02 Oct 2024 Direct F2
transaction RNAC Common Stock Other -2,119,193 -80% 529,798 02 Oct 2024 See Footnote F1, F3
transaction RNAC Common Stock Other +317,879 +2480% 330,695 02 Oct 2024 By wife F1
transaction RNAC Common Stock Purchase $544,576 +29,847 +0.38% $18.25 7,853,406 03 Oct 2024 Direct F4
transaction RNAC Common Stock Purchase $194,859 +10,249 +0.13% $19.01 7,863,655 03 Oct 2024 Direct F5
transaction RNAC Common Stock Purchase $1,018,878 +50,489 +0.64% $20.18 7,914,144 03 Oct 2024 Direct F6
transaction RNAC Common Stock Purchase $450,560 +21,278 +0.27% $21.17 7,935,422 03 Oct 2024 Direct F7
transaction RNAC Common Stock Purchase $175,840 +8,043 +0.1% $21.86 7,943,465 03 Oct 2024 Direct F8
transaction RNAC Common Stock Purchase $211,195 +9,892 +0.12% $21.35 7,953,357 04 Oct 2024 Direct F9
transaction RNAC Common Stock Purchase $1,092,673 +48,880 +0.61% $22.35 8,002,237 04 Oct 2024 Direct F10
transaction RNAC Common Stock Purchase $392,372 +16,650 +0.21% $23.57 8,018,887 04 Oct 2024 Direct F11
transaction RNAC Common Stock Purchase $116,769 +4,879 +0.06% $23.93 8,023,766 04 Oct 2024 Direct F12

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Warrant (Right to Buy) Other -133,632 -80% 33,408 02 Oct 2024 Common Stock 133,632 $46.50 See Footnote F1, F3
transaction RNAC Warrant (Right to Buy) Other +113,587 113,587 02 Oct 2024 Common Stock 113,587 $46.50 Direct F1
transaction RNAC Warrant (Right to Buy) Other +20,045 20,045 02 Oct 2024 Common Stock 20,045 $46.50 By wife F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution for no consideration from TAS Partners LLC to the reporting person or the reporting person's spouse, as the case may be. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
F2 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.17 to $17.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
F4 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.76 to $18.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $18.76 to $19.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $19.77 to $20.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.78 to $21.77. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F8 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.80 to $22.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F9 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.87 to $21.86. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F10 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.87 to $22.8626. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F11 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $22.87 to $23.8699. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F12 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $23.87 to $24.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.